Polaris Venture Management Co Iv Llc - Net Worth and Insider Trading

Polaris Venture Management Co Iv Llc Net Worth

The estimated net worth of Polaris Venture Management Co Iv Llc is at least $1 Million dollars as of 2024-11-09. Polaris Venture Management Co Iv Llc is the of Alimera Sciences Inc and owns about 206,052 shares of Alimera Sciences Inc (ALIM) stock worth over $1 Million. Details can be seen in Polaris Venture Management Co Iv Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Polaris Venture Management Co Iv Llc has not made any transactions after 2013-07-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Polaris Venture Management Co Iv Llc

To

Polaris Venture Management Co Iv Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Polaris Venture Management Co Iv Llc owns 7 companies in total, including Lyra Therapeutics Inc (LYRA) , Pulmatrix Inc (PULM) , and Acceleron Pharma Inc (XLRN) among others .

Click here to see the complete history of Polaris Venture Management Co Iv Llc’s form 4 insider trades.

Insider Ownership Summary of Polaris Venture Management Co Iv Llc

Ticker Comapny Transaction Date Type of Owner
LYRA Lyra Therapeutics Inc 2020-04-30 10 percent owner
PULM Pulmatrix Inc 2018-04-03 10 percent owner
XLRN Acceleron Pharma Inc 2014-06-02 other: Former 10% Owner
LIMIT LIMIT 2014-04-10 10 percent owner
LIMIT LIMIT 2013-07-17 10 percent owner & other: May be part of 13(d) group.
LIMIT LIMIT 2007-05-16 10 percent owner
LIMIT LIMIT 2010-05-12 10 percent owner

Polaris Venture Management Co Iv Llc Latest Holdings Summary

Polaris Venture Management Co Iv Llc currently owns a total of 1 stock. Polaris Venture Management Co Iv Llc owns 206,052 shares of Alimera Sciences Inc (ALIM) as of July 17, 2013, with a value of $1 Million.

Latest Holdings of Polaris Venture Management Co Iv Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALIM Alimera Sciences Inc 2013-07-17 206,052 5.54 1,141,528

Holding Weightings of Polaris Venture Management Co Iv Llc


Polaris Venture Management Co Iv Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Polaris Venture Management Co Iv Llc has made a total of 0 transactions in Alimera Sciences Inc (ALIM) over the past 5 years. The most-recent trade in Alimera Sciences Inc is the sale of 8,196 shares on July 17, 2013, which brought Polaris Venture Management Co Iv Llc around $590,098.

Insider Trading History of Polaris Venture Management Co Iv Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Polaris Venture Management Co Iv Llc Trading Performance

GuruFocus tracks the stock performance after each of Polaris Venture Management Co Iv Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Polaris Venture Management Co Iv Llc is -33.45%. GuruFocus also compares Polaris Venture Management Co Iv Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Polaris Venture Management Co Iv Llc within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Polaris Venture Management Co Iv Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Polaris Venture Management Co Iv Llc

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -26.46 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -19.65 LIMIT LIMIT LIMIT LIMIT LIMIT

Polaris Venture Management Co Iv Llc Ownership Network

Ownership Network List of Polaris Venture Management Co Iv Llc

No Data

Ownership Network Relation of Polaris Venture Management Co Iv Llc

Insider Network Chart

Polaris Venture Management Co Iv Llc Owned Company Details

What does Lyra Therapeutics Inc do?

Who are the key executives at Lyra Therapeutics Inc?

Polaris Venture Management Co Iv Llc is the 10 percent owner of Lyra Therapeutics Inc. Other key executives at Lyra Therapeutics Inc include director & Executive Chair Harlan Waksal , 10 percent owner Nbvm Gp, Llc , and director & 10 percent owner Edward T Anderson .

Lyra Therapeutics Inc (LYRA) Insider Trades Summary

Over the past 18 months, Polaris Venture Management Co Iv Llc made no insider transaction in Lyra Therapeutics Inc (LYRA). Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net purchase of 3,610,832 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 1,805,416 shares made by Edward T Anderson , and a net purchase of 1,805,416 shares made by Nbvm Gp, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 7,246,664 shares were bought by its insiders, resulting in a net purchase of 7,246,664 shares.

Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lyra Therapeutics Inc Insider Transactions

No Available Data

Polaris Venture Management Co Iv Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Polaris Venture Management Co Iv Llc. You might contact Polaris Venture Management Co Iv Llc via mailing address: One Marina Park Drive, 10th Floor, Boston Ma 02210.